Phibro Animal Health Corp 8-K Filing
Ticker: PAHC · Form: 8-K · Filed: Nov 4, 2025 · CIK: 1069899
| Field | Detail |
|---|---|
| Company | Phibro Animal Health Corp (PAHC) |
| Form Type | 8-K |
| Filed Date | Nov 4, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $0.12 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Phibro Animal Health Corp (ticker: PAHC) to the SEC on Nov 4, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (ich registered Class A Common Stock, $0.0001 par value per share PAHC NASDAQ Sto); $0.12 (aration of a quarterly cash dividend of $0.12 per share on its Class A common stock a).
How long is this filing?
Phibro Animal Health Corp's 8-K filing is 2 pages with approximately 477 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 477 words · 2 min read · ~2 pages · Grade level 12.9 · Accepted 2025-11-04 16:15:56
Key Financial Figures
- $0.0001 — ich registered Class A Common Stock, $0.0001 par value per share PAHC NASDAQ Sto
- $0.12 — aration of a quarterly cash dividend of $0.12 per share on its Class A common stock a
Filing Documents
- tm2530138d1_8k.htm (8-K) — 25KB
- tm2530138d1_ex99-1.htm (EX-99.1) — 3KB
- tm2530138d1_ex99-1img01.jpg (GRAPHIC) — 5KB
- 0001104659-25-106292.txt ( ) — 198KB
- pahc-20251104.xsd (EX-101.SCH) — 3KB
- pahc-20251104_lab.xml (EX-101.LAB) — 33KB
- pahc-20251104_pre.xml (EX-101.PRE) — 22KB
- tm2530138d1_8k_htm.xml (XML) — 4KB
01
ITEM 8.01 OTHER EVENTS On November 4, 2025, Phibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 17, 2025, to stockholders of record at the close of business on November 26, 2025. A copy of the press release announcing the dividend is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
FINANCIAL STATEMENTS AND EXHIBITS
FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated November 4, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. PHIBRO ANIMAL HEALTH CORPORATION Registrant Date: November 4, 2025 By: /s/ Judith Weinstein Name: Judith Weinstein Title: Senior Vice President, General Counsel and Corporate Secretary